No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Agents / pharmacology
-
Boron Compounds / pharmacology
-
Bortezomib / pharmacology
-
Drug Resistance, Neoplasm / genetics*
-
Gene Expression Profiling / methods*
-
Glycine / analogs & derivatives
-
Glycine / pharmacology
-
Histone Deacetylase Inhibitors / pharmacology*
-
Humans
-
Hydroxamic Acids / pharmacology
-
Lymphoma, Large B-Cell, Diffuse / drug therapy
-
Lymphoma, Large B-Cell, Diffuse / genetics
-
Lymphoma, Large B-Cell, Diffuse / metabolism
-
Male
-
Mice, SCID
-
Prognosis
-
Proteasome Inhibitors / pharmacology*
-
U937 Cells
-
Vorinostat
-
Xenograft Model Antitumor Assays
Substances
-
Antineoplastic Agents
-
Boron Compounds
-
Histone Deacetylase Inhibitors
-
Hydroxamic Acids
-
MLN2238
-
Proteasome Inhibitors
-
Vorinostat
-
Bortezomib
-
Glycine